Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
Clasificación en acciones #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Precio por acción
$0.05137558
Última sincronización: 2026-08-13
Capitalización bursátil
$1.88M
Cambio (1 día)
0.00%
Cambio (1 año)
-11.66%
País
CA
Comercio Restart Life Sciences Corp. (HEAL)

Categoría

Ratio P/B de Restart Life Sciences Corp. (HEAL)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Restart Life Sciences Corp., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Restart Life Sciences Corp. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE